Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

594
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
594

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mediating effect of social determinants of health between race and phthalate biomarkers in pregnancy.

Pregnancy (Hoboken, N.J.)·2026
Same author

Importance of placental evaluation in pregnancies at high risk for placenta accreta spectrum: Expert clinical perspective.

Pregnancy (Hoboken, N.J.)·2026
Same author

Longitudinal patterns of urinary biomarkers of placental and renal function in pregnancy and associations with early pregnancy exposure to phthalates and replacements.

Reproductive toxicology (Elmsford, N.Y.)·2026
Same author

Considerations for the Analysis of Urinary Environmental Chemical Concentrations During Pregnancy.

Epidemiology (Cambridge, Mass.)·2026
Same author

Guidelines on Placenta Accreta Spectrum Disorders: A Systematic Review.

Obstetrical & gynecological survey·2026
Same author

Advances in Imaging for Placenta Accreta Spectrum Disorder.

Obstetrics and gynecology·2025
Same journal

Congenital cytomegalovirus: Screening strategies and diagnostic challenges.

Seminars in perinatology·2026
Same journal

The society for neonatal nutrition and lifelong health: Building science and translating research to inform neonatal nutritional care.

Seminars in perinatology·2026
Same journal

Enteral nutrition to optimize health and neurodevelopmental outcomes in very preterm infants.

Seminars in perinatology·2026
Same journal

Standardizing outcome measures in preterm infant nutrition research: Use of anthropometry and body composition in the neonatal intensive care unit.

Seminars in perinatology·2026
Same journal

A dilemma of parental inclusion? Parent perspectives of NICU feeding practices and neonatal nutritional research.

Seminars in perinatology·2026
Same journal

Maternal diet and nutritional status during pregnancy and lactation: a review of implications on milk composition and lactation outcomes.

Seminars in perinatology·2026
See all related articles

Related Experiment Video

Updated: May 6, 2026

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
04:08

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes

Published on: June 27, 2025

1.3K

Morbidly adherent placenta.

Alfred Abuhamad1

  • 1Department of Obstetrics & Gynecology, Eastern Virginia Medical School, Hofheimer Hall, 825 Fairfax Ave, Suite 310, Norfolk, VA 23507.

Seminars in Perinatology
|November 2, 2013
PubMed
Summary
This summary is machine-generated.

Morbidly adherent placenta, including placenta accreta, involves abnormal placental implantation. Early ultrasound diagnosis and a multidisciplinary team approach are crucial for successful management and delivery.

Keywords:
Placenta accretaPlacenta incretaPlacenta percretaPlacenta previaUltrasound

More Related Videos

A Simple Protocol for Platelet-mediated Clumping of Plasmodium falciparum-infected Erythrocytes in a Resource Poor Setting
07:27

A Simple Protocol for Platelet-mediated Clumping of Plasmodium falciparum-infected Erythrocytes in a Resource Poor Setting

Published on: May 16, 2013

21.1K
Ex Vivo Perfusion of the Rodent Placenta
06:54

Ex Vivo Perfusion of the Rodent Placenta

Published on: May 30, 2019

12.8K

Related Experiment Videos

Last Updated: May 6, 2026

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
04:08

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes

Published on: June 27, 2025

1.3K
A Simple Protocol for Platelet-mediated Clumping of Plasmodium falciparum-infected Erythrocytes in a Resource Poor Setting
07:27

A Simple Protocol for Platelet-mediated Clumping of Plasmodium falciparum-infected Erythrocytes in a Resource Poor Setting

Published on: May 16, 2013

21.1K
Ex Vivo Perfusion of the Rodent Placenta
06:54

Ex Vivo Perfusion of the Rodent Placenta

Published on: May 30, 2019

12.8K

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Diagnostic Imaging

Background:

  • Morbidly adherent placenta (MAP), encompassing placenta accreta, increta, and percreta, is characterized by abnormal placental implantation into the uterine wall.
  • The incidence of MAP has risen significantly, with prior cesarean section and placenta previa as primary risk factors.

Purpose of the Study:

  • To review the diagnostic modalities and management strategies for morbidly adherent placenta.
  • To emphasize the importance of early prenatal diagnosis and multidisciplinary care.

Main Methods:

  • Review of sonographic markers for MAP, detectable from the first trimester.
  • Discussion of the role of ultrasound and MRI in diagnosis.
  • Outline of optimal timing for planned delivery and the necessity of a multidisciplinary team approach.

Main Results:

  • Ultrasound demonstrates high sensitivity and specificity for diagnosing MAP.
  • Key sonographic markers include abnormal gestational sac implantation, placental lacunae, and altered uterine-placental interface.
  • MRI is reserved for non-diagnostic ultrasound cases.

Conclusions:

  • Prenatal diagnosis of MAP via ultrasound is critical for effective management.
  • Planned delivery around 34-35 weeks with corticosteroid administration is recommended.
  • Successful management hinges on a multidisciplinary team and meticulous surgical preparation.